These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21822175)

  • 41. Listening to patients with rare diseases.
    Lancet; 2009 Mar; 373(9667):868. PubMed ID: 19286064
    [No Abstract]   [Full Text] [Related]  

  • 42. From the Editor's desk.....: February 2017.
    Moreau R; Bataller R; Berg T; Zucman-Rossi J; Jalan R
    J Hepatol; 2017 Feb; 66(2):263-266. PubMed ID: 28104087
    [No Abstract]   [Full Text] [Related]  

  • 43. [Rare diseases: medicine's challenge in the XXI Century].
    Sánchez-Valverde F; García Fuentes M
    An Sist Sanit Navar; 2008; 31 Suppl 2():5-8. PubMed ID: 18953368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rare diseases. A national network to benefit early diagnosis and more effective therapies].
    Taruscio D; Kodra Y
    Epidemiol Prev; 2011; 35(5-6 Suppl 2):92-3. PubMed ID: 22166875
    [No Abstract]   [Full Text] [Related]  

  • 46. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry.
    Benito-Lozano J; López-Villalba B; Arias-Merino G; Posada de la Paz M; Alonso-Ferreira V
    Orphanet J Rare Dis; 2022 Nov; 17(1):418. PubMed ID: 36397119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].
    Frank M; Eidt-Koch D; Aumann I; Reimann A; Wagner TO; Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1216-23. PubMed ID: 25209683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Empyema as an orphan disease: So many approaches and so few data.
    Heffner JE
    J Infect Public Health; 2009; 2(1):1-3. PubMed ID: 20701854
    [No Abstract]   [Full Text] [Related]  

  • 50. [Mistakes in diagnostics and treatment of soft tissue sarcomas].
    Tepliakov VV; Karpenko VIu; Sedykh SA; Volchenko NN; Shatalov AM; Epifanova SV
    Khirurgiia (Mosk); 2011; (1):36-42. PubMed ID: 21350402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.
    Boycott KM; Lau LP; Cutillo CM; Austin CP
    EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 30979709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients].
    Laimer M; Prodinger C; Ahlgrimm-Siess V; Hintner H; Bauer JW
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):261-4. PubMed ID: 25721645
    [No Abstract]   [Full Text] [Related]  

  • 53. Rare diseases: the bane of modern society and the quest for cures.
    Azie N; Vincent J
    Clin Pharmacol Ther; 2012 Aug; 92(2):135-9. PubMed ID: 22814654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. General knowledge and opinion of future health care and non-health care professionals on rare diseases.
    Ramalle-Gómara E; Ruiz E; Quiñones C; Andrés S; Iruzubieta J; Gil-de-Gómez J
    J Eval Clin Pract; 2015 Apr; 21(2):198-201. PubMed ID: 25363689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Team-Based Approach to Undiagnosed and Rare Diseases.
    Kliegman RM; Ruggeri BE; Smith MM
    Pediatr Clin North Am; 2017 Feb; 64(1):17-26. PubMed ID: 27894443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Conceptual Framework for Decision-making Support in Uncertainty- and Risk-based Diagnosis of Rare Clinical Cases by Specialist Physicians.
    Santos AA; Moura JA; de Araújo JM
    Stud Health Technol Inform; 2015; 216():857-61. PubMed ID: 26262173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Legal and regulatory aspects of orphan drugs.
    Shani S; Yahalom Z
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():110-5. PubMed ID: 24380129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyroid cancer is rare. Foreword.
    Harmer C
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):393. PubMed ID: 20471228
    [No Abstract]   [Full Text] [Related]  

  • 59. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rare diseases and effective treatments: are we delivering?
    Luzzatto L; Hollak CE; Cox TM; Schieppati A; Licht C; Kääriäinen H; Merlini G; Schaefer F; Simoens S; Pani L; Garattini S; Remuzzi G
    Lancet; 2015 Feb; 385(9970):750-2. PubMed ID: 25752159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.